Shares of Atlas Arteria Limited (OTCMKTS:MAQAF – Get Free Report) were down 10.5% during mid-day trading on Tuesday. The stock traded as low as $2.64 and last traded at $2.64. 360 shares traded hands during mid-day trading, a decline of 70% from the average daily volume of 1,203 shares. The stock had previously closed at $2.95.
Wall Street Analysts Forecast Growth
Several equities research analysts recently commented on the company. Royal Bank Of Canada cut Atlas Arteria to an “underperform” rating and set a $4.75 target price for the company. in a research note on Thursday, July 2nd. Jefferies Financial Group raised Atlas Arteria to a “buy” rating and set a $5.31 price target on the stock in a research note on Thursday, August 27th. One research analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $5.03.
Check Out Our Latest Analysis on Atlas Arteria
Atlas Arteria Price Performance
The company’s 50-day moving average is $3.26 and its two-hundred day moving average is $3.34.
Atlas Arteria Company Profile
Atlas Arteria Group is an owner and manager of transportation infrastructure assets, with a focus on toll roads and related concessions. The company invests in, develops and operates long-term road infrastructure under public-private partnership and concession arrangements, generating revenue from toll collections and other transportation-related activities.
Atlas Arteria’s portfolio includes interests in the APRR and AREA motorway networks in France, which together form one of the country’s major tolled motorway systems.
Recommended Stories
- Five stocks we like better than Atlas Arteria
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Atlas Arteria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atlas Arteria and related companies with MarketBeat.com's FREE daily email newsletter.
